Literature DB >> 8833434

Human immunodeficiency virus and the brain.

J D Glass1, R T Johnson.   

Abstract

Human immunodeficiency virus (HIV) infects the nervous system in the majority of patients, causing a variety of neurological syndromes throughout the course of the disease. This review focuses on the effects of HIV in the central nervous system, with an emphasis on HIV-associated dementia. HIV-associated dementia occurs in a subset of patients with AIDS; it is unclear why these patients and not all patients develop the disease. Several factors are likely to be involved in the pathogenesis of HIV-associated dementia, including neurotoxins released from the virus and/or infected macrophages and microglia, immunologic dysregulation of macrophage function, and specific genetic strains of HIV. These factors, and their possible interactions, are discussed.

Entities:  

Mesh:

Year:  1996        PMID: 8833434     DOI: 10.1146/annurev.ne.19.030196.000245

Source DB:  PubMed          Journal:  Annu Rev Neurosci        ISSN: 0147-006X            Impact factor:   12.449


  26 in total

1.  Neural stem cells as engraftable packaging lines can mediate gene delivery to microglia: evidence from studying retroviral env-related neurodegeneration.

Authors:  W P Lynch; A H Sharpe; E Y Snyder
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Reservoirs for HIV-1.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

Review 3.  Effects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergism.

Authors:  Lindsay Festa; Olimpia Meucci
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

4.  HIV latency: present knowledge, future directions.

Authors:  Xavier Contreras; Tina Lenasi; B Matija Peterlin
Journal:  Future Virol       Date:  2006       Impact factor: 1.831

5.  A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses.

Authors:  N Shimizu; Y Soda; K Kanbe; H Y Liu; R Mukai; T Kitamura; H Hoshino
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Neuronal glycolytic pathway impairment induced by HIV envelope glycoprotein gp120.

Authors:  A L Vignoli; I Martini; K G Haglid; L Silvestroni; G Augusti-Tocco; S Biagioni
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

7.  Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4(+) T lymphocytes by combination of cytokines.

Authors:  R Ghose; L Y Liou; C H Herrmann; A P Rice
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia.

Authors:  Xiaojuan Liu; Malabendu Jana; Subhajit Dasgupta; Sreenivas Koka; Jun He; Charles Wood; Kalipada Pahan
Journal:  J Biol Chem       Date:  2002-08-07       Impact factor: 5.157

Review 9.  Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementia.

Authors:  Ramendra N Saha; Kalipada Pahan
Journal:  J Neurochem       Date:  2003-09       Impact factor: 5.372

10.  Increased activity of matrix metalloproteinase-2 in human glial and neuronal cell lines treated with HIV-1 gp41 peptides.

Authors:  Y H Chong; J Y Seoh; H K Park
Journal:  J Mol Neurosci       Date:  1998-04       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.